Anadys

3 Reasons Hep C Premiums Might Not Last
Motley Fool
Tue, 01/10/12 - 09:50 am
hepatitis C
Anadys
Roche
Gilead
Pharmasset
Bristol-Myers Squibb
Inhibitex
Roche: New Era Of Hepatitis Therapies Creates Short-Term Threat, Long-Term Opportunity
Seeking Alpha
Sun, 10/23/11 - 10:49 am
Roche
Anadys
hepatitis C
ANA773
Abbott Laboratories
Anadys acquisition sign of more to come
The Deal
Tue, 10/18/11 - 08:53 am
Anadys
Roche
Merck
JNJ
Achillion
M&A
Indenix
Bristol-Myers Squibb
Roche's All-Oral Hep C Therapy Could Be First, Not Best, to Reach Market
TheStreet.com
Mon, 10/17/11 - 01:22 pm
Roche
M&A
Anadys
hepatitis C
Pegasys
setrobuvir
Merck
Victrelis
RG7128
Pharmasset
Swiss pharma giant Roche to buy US-based hepatitis C specialist Anadys for $230 million
Yahoo/AP
Mon, 10/17/11 - 09:27 am
Roche
M&A
Anadys
hepatitis C
Hep C Drug Updates: Vertex and Anadys
TheStreet.com
Thu, 10/13/11 - 12:21 pm
Vertex
Anadys
hepatitis C
Incivek
setrobuvir
12 Cancer Stocks Being Snapped Up by Insiders
Seeking Alpha
Fri, 08/19/11 - 12:09 pm
OPKO Health
Tengion
GTx
Anadys
Complete Genomics
Amag Pharmaceuticals
MannKind
Threshold Pharmaceuticals
Synta
Genomic Health
Ziopharm
Ardea
ANA598 Data Presented at AASLD Highlight Positive Clinical Profile of DAA Entering Phase IIb
Yahoo/PR NewsWire
Sat, 10/30/10 - 12:17 pm
hepatitis C
Anadys
ANA598
15 Biotech Stocks With the Lowest Put/Call Ratios
Seeking Alpha
Wed, 10/13/10 - 12:09 pm
biotech
Anadys
BioSante
Cerus
CompuGen
Cytokinetics
Cell Therapeutics
Idera Pharmaceuticals
Medivation
MDRA
RXi Pharmaceuticals
Sangamo BioSciences
Talecris
3SBio
Vical
Trimeris
Anadys mulls strategic options on hepatitis C drug
Yahoo/AP
Thu, 05/27/10 - 10:29 am
Anadys
hepatitis C
Spotlight on Anadys, Keryx as biotechs' shares trade higher
MarketWatch
Sat, 05/22/10 - 09:39 am
Anadys
Keryx
biotech
Abbott falls on acquisition deal; Anadys climbs
Marketwatch
Fri, 05/21/10 - 11:14 am
Abbott Laboratories
Anadys
M&A
Piramal Healthcare
Biotech Calendar: Key Dates for April
TheStreet.com
Mon, 04/5/10 - 09:53 am
Forest Labs
Celgene
Genzyme
Lexicon Pharmaceuticals
Cell Therapeutics
Acadia
Acorda Therapeutics
Vertex Pharmaceuticals
Indenix
Pozen
Acura Pharmaceuticals
OSI Pharmaceuticals
Cyclacel
Peregrine Pharmaceuticals
Anadys
Pharmasset
Dendreon
Anadys study results show little difference between hepatitis C drug, placebo; shares slide
Yahoo/AP
Thu, 02/25/10 - 09:06 am
hepatitis C
Anadys
Anadys Pharmaceuticals Provides Progress Update On Phase II Study Of ANA598 In Hepatitis C Patients
Medical News Today
Sat, 01/23/10 - 11:29 am
Anadys
hepatitis C
FDA Calendar Updates: Anadys, Merck, Schering-Plough
Seeking Alpha
Fri, 07/31/09 - 08:17 am
FDA
Merck
Schering Plough
Anadys
Anadys Financing Tempers Hope for Hep C Deal
TheStreet.com
Thu, 06/4/09 - 10:48 am
Anadys
hepatitis C
ANA598
Anadys Pharmaceuticals to Report First Quarter 2009 Financial Results
Yahoo
Sat, 04/18/09 - 11:33 am
Anadys
Anadys Tries to Tempt Suitors With Hep C Data
TheStreet.com
Tue, 04/7/09 - 05:04 am
Anadys
hepatitis C
Looking for the Biotech Breakout
Seeking Alpha
Mon, 01/19/09 - 09:13 am
biotech
Biotech Ishares
Anadys
Cypress Bioscience
CV Therapeutics
Valeant Pharmaceuticals
Illumina
Biogen Idec
Life Technologies
Sequenom
Biomarin

Pages